
Anixa Biosciences ANIX
$ 2.61
2.35%
Quarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences PEG Ratio 2011-2026 | ANIX
Annual PEG Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0 | -0 | -0.000001 | -0 | -1.09 | -0.252 | -0.257 | 0.136 | 0.516 | 0.0426 | -0.233 | -0.212 | 0.03 | -0.188 | 0.0969 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.516 | -1.09 | -0.0941 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
2.05 | $ 115.18 | -0.26 % | $ 35 B | ||
|
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
0.283 | $ 16.21 | 0.06 % | $ 175 M | ||
|
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | ||
|
IQVIA Holdings
IQV
|
1.57 | $ 170.71 | -1.47 % | $ 29.3 B | ||
|
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 17.85 | -2.51 % | $ 951 M | ||
|
Biodesix
BDSX
|
1.09 | $ 15.52 | 2.95 % | $ 2.01 B | ||
|
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-0.0105 | $ 2.16 | -0.46 % | $ 4.96 M | ||
|
BioNano Genomics
BNGO
|
-0.000157 | $ 1.17 | -2.92 % | $ 6.37 M | ||
|
Co-Diagnostics
CODX
|
-0.000246 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 167.37 | -3.75 % | $ 8.3 B | ||
|
Castle Biosciences
CSTL
|
0.278 | $ 24.86 | 0.08 % | $ 691 M | ||
|
Danaher Corporation
DHR
|
210 | $ 192.01 | 0.47 % | $ 137 B | ||
|
Celcuity
CELC
|
-0.769 | $ 113.96 | 1.18 % | $ 5.33 B | ||
|
DexCom
DXCM
|
1.12 | $ 62.95 | 1.17 % | $ 24.6 B | ||
|
Fulgent Genetics
FLGT
|
-0.00389 | $ 16.5 | -1.93 % | $ 499 M | ||
|
Chembio Diagnostics
CEMI
|
-0.0363 | - | 0.22 % | $ 16.8 M | ||
|
Guardant Health
GH
|
-3.43 | $ 89.89 | -4.2 % | $ 11.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 198.66 | 0.76 % | $ 22.1 B | ||
|
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
1.16 | $ 109.23 | -4.34 % | $ 9.01 B | ||
|
Illumina
ILMN
|
2.16 | $ 127.74 | 0.28 % | $ 20.3 B | ||
|
Interpace Biosciences
IDXG
|
-0.00238 | $ 1.97 | 0.63 % | $ 8.72 M | ||
|
Laboratory Corporation of America Holdings
LH
|
22.7 | $ 274.86 | 0.42 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 76.46 | 0.47 % | $ 5.16 B | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 495.18 | -0.64 % | $ 14.3 B | ||
|
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | ||
|
Mettler-Toledo International
MTD
|
4.59 | $ 1 262.91 | 0.24 % | $ 26 B | ||
|
Myriad Genetics
MYGN
|
-0.00983 | $ 4.72 | -0.53 % | $ 437 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.000061 | $ 4.6 | -1.92 % | $ 3.62 M | ||
|
NeoGenomics
NEO
|
0.0904 | $ 8.0 | - | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 9.47 | 0.64 % | $ 2.05 B | ||
|
National Research Corporation
NRC
|
-7.14 | $ 17.38 | 1.25 % | $ 389 M |